Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiaceutics Share News (DXRX)

Share Price Information for Diaceutics (DXRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 123.50
Bid: 122.00
Ask: 125.00
Change: -2.50 (-1.98%)
Spread: 3.00 (2.459%)
Open: 126.00
High: 123.50
Low: 123.00
Prev. Close: 126.00
DXRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Diaceutics wins two deals; Faron proposes placing

Fri, 27th Jan 2023 18:56

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Diaceutics PLC - Belfast-based testing laboratories company - Signs two enterprise-level, multi-disease data engagements with two pharmaceutical companies with a combined value of USD7 million over a two-year period. Says that the agreements are for its subscription data services. Reports that revenue in 2022 increased 44% to GBP20.0 million from GBP13.9 million in 2021. Adds that revenue is materially ahead of market expectations. Expects earnings before interest, tax, depreciation, and amortization to be in line with market expectations, with an with Ebitda margin similar to 2021. Attributes growth to demand from its pharmaceutical and life science customers.

----------

ICG-Longbow Senior Secured UK Property Debt Investments Ltd - Resolves to return 5.50 pence per ordinary share to shareholders, being GBP6.7 million in total based on the current number of ordinary shares in issue.

----------

Ilika PLC - Hampshire, England-based solid-state battery technology provider - Reports that it is leading a 24-month GBP8.2 million Faraday Battery Challenge collaboration programme "to integrate high silicon content electrodes into its Goliath solid-state batteries to enable automotive level performance". Adds that it will receive a GBP2.8 million grant over the 24-month programme.

----------

Mercia Asset Management PLC - Warwickshire, England-based, regionally-focused asset manager - Says that the final payment of GBP2.1million in relation to its acquisition of a venture capital trust fund management business from NVM Private Equity LLP has become payable. Plans to pay through the issue of 6.5 million new deferred consideration shares at 32.45p each. Expects the deferred consideration shares to start trading on AIM on January 31.

----------

Time Out Group PLC - media and hospitality business - Signs a lease deal with Klepierre Real Estate Espana SLU to open market in Barcelona in the first half of 2024. Says that Time Out Market Barcelona will be located in the Maremagnum shopping and leisure destination in the Port Vell, across 56,500 square feet. Says that this opening increases the line-up of new sites to eight markets in development which are set to open between 2023 and 2027. Does not disclose any details about the lease. "Barcelona is globally regarded as one of the top food destinations in the world and is a perfect fit for our brand. We are excited to bring Time Out Market to this fabulous, vibrant city together with our partners Klepierre and Estrella Damm. We now have an incredibly strong line-up of new Markets that will open in the next few years and with interest from landlords and real estate developers stronger than ever, we expect to further accelerate the signing of new Markets in the year ahead," Co-CEO Jay Coldren says.

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based biopharmaceutical drug discovery and development company - Proposes a private placing to raise EUR11.0 million through an accelerated book-building directed at institutional and other investors. Adds that the subscription price per placing share is to be determined on the basis of the bids received in the bookbuild in euros. Says the Finland Branch of Carnegie Investment Bank AB is acting as sole bookrunner and lead manager in the placing.

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
8 Jul 2020 08:06

Diaceutics builds on strong Q1, trades in line

(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Wednesday that it had built on its good start to the financial year, with trading in the first half in line with expectations.

Read more
11 Jun 2020 14:18

UPDATE: Diaceutics Raises Almost GBP21 Million Ahead Of DXRX Launch

UPDATE: Diaceutics Raises Almost GBP21 Million Ahead Of DXRX Launch

Read more
11 Jun 2020 13:26

Diaceutics Raises Almost GBP21 Million Ahead Of DXRX Platform Launch

Diaceutics Raises Almost GBP21 Million Ahead Of DXRX Platform Launch

Read more
11 Jun 2020 12:33

Diaceutics raising £20.5m ahead of launch of new platform

(Sharecast News) - Diagnostics commercialisation company Diaceutics has conditionally raised £20.5m before expenses, through a placing of 14,137,931 new shares at 145p each to existing and new investors in two tranches, it announced on Thursday.

Read more
19 May 2020 10:56

Diaceutics maintains expectations after first quarter

(Sharecast News) - Diaceutics said it had made a "good start" to the 2020 financial year on Tuesday, with trading in the first quarter in line with the board's expectations.

Read more
29 Apr 2020 09:29

Diaceutics flags serious fall in cancer testing amid Covid-19

(Sharecast News) - Precision diagnostics commercialisation company Diaceutics announced research results from its Covid-19 oncology tracker on Wednesday, which it said showed the impact of the crisis on cancer testing and diagnosis in the United States.

Read more
16 Mar 2020 14:41

Diaceutics Records Profit Fall In 2019 As Expenses Rise

Diaceutics Records Profit Fall In 2019 As Expenses Rise

Read more
13 Jan 2020 10:44

Diaceutics beats expectations on revenue and earnings

(Sharecast News) - Pharmaceutical data analytics and implementation services provider Diaceutics updated the market on its trading for the year ended 31 December on Monday, reporting that as a result of a strong trading performance in the final quarter, underpinned by an increase in the number of clients and an accelerated growth in product sales, its revenue and adjusted EBITDA for the year were expected to be around £13.4m and above £2.1m, respectively.

Read more
13 Jan 2020 10:33

Diaceutics To Exceed 2019 Earnings Guidance, Shares Rise

Diaceutics To Exceed 2019 Earnings Guidance, Shares Rise

Read more
9 Sep 2019 11:26

Diaceutics Maiden Loss Deepens On Listing Costs; Revenue Jumps

(Alliance News) - Pharmaceuticals-focused data analytics firm Diaceutics PLC said Monday its maiden interim loss deepened amid listing costs, despite revenue rising a third on the year March, in

Read more
8 Aug 2019 14:43

Diaceutics Appoints Former Openet General Manager As Global Data Head

(Alliance News) - Diaceutics PLC on Thursday said it has appointed the former general manager of Cloud & Data at Openet to be its new head of Global Data.Derek Hosty will join the data

Read more
8 Jul 2019 11:48

Diaceutics To Achieve First Half Market Expectations On Strong Sales

(Alliance News) - Diaceutics PLC on Monday said it has moved to a net cash position after retiring all outstanding debt from its balance sheet, and is on track for market in the company, which and

Read more
17 Jun 2019 11:13

Diaceutics Invests GBP1 Million For 16 Million More Patient Records

(Alliance News) - Diaceutics PLC on Monday said it has invested GBP1 million to expand and enhance its data lake by acquiring another 16 million patient records a year.Diaceutics is a data

Read more
21 Mar 2019 09:55

Diaceutics begins listed company life on AIM

(Sharecast News) - Data analytics and implementation services company Diaceutics confirmed the admission of its entire issued ordinary share capital, which comprises 69,583,077 ordinary shares, to trading on AIM on Thursday morning.

Read more
21 Mar 2019 08:40

Diaceutics Shares Up 19% After Raising GBP17 Million In AIM IPO (ALLIPO)

LONDON (Alliance News) - Diaceutics PLC said Thursday its shares have been admitted to trading on AIM after raising GBP17 million as part of its initial public offering.Diaceutics is a data

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.